Regulus Therapeutics to Present at the Canaccord Genuity 44th Annual[...]
Nearly Six out of 10 Consumers Betting $500 or More Per Month Online[...]
VolitionRx Limited Schedules Second Quarter 2024 Earnings Conference[...]
06/08/2024 | Press release | Distributed by Public on 06/08/2024 12:01
Please select the service you want to use:
Smartlinks | Seres Therapeutics Inc. | News | Health | Company News | Business Announcement | Contracts and Orders | Securities Issuers | Biotechnology and Medical Research Companies | Frankfurt Stock Exchange | Berlin Stock Exchange | Stuttgart Stock Exchange | BX Swiss | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact